In Korea, Mycoplasma pneumoniae was detected in 255/2,089 respiratory specimens collected during 2000–2011; 80 isolates carried 23S rRNA gene mutations, and 69/123 culture-positive samples with the mutation were resistant to 5 macrolides. During 2000–2011, prevalence of the mutation increased substantially. These findings have critical implications for the treatment of children with mycoplasma pneumonia
We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan d...
Abstract Background With the emergence of macrolide resistance, concerns about the efficacy of macro...
The molecular characteristics of 480 Mycoplasma pneumoniae polymerase chain reaction-positive specim...
In Korea, Mycoplasma pneumoniae was detected in 255/2,089 respiratory specimens collected during 200...
PurposeMacrolide resistance rate of Mycoplasma pneumoniae has rapidly increased in children. Studies...
To investigate the genetic background for the emergence of macrolide resistance, we characterized th...
Mycoplasma pneumoniae accounts for 10-30% of community-acquired pneumonia (CAP) in children. This st...
To investigate the genetic background for the emergence of macrolide resistance, we characterized th...
The development of macrolide resistance that occurred during 3 days of therapy with azithromycin to ...
Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens a...
SummaryThe development of macrolide resistance that occurred during 3 days of therapy with azithromy...
The resistance rate of 67 Mycoplasma pneumoniae isolates from 356 ambulatory adult patients with res...
Background: The proportion of Mycoplasma pneumoniae isolates carrying point mutations in the 23S reg...
Macrolide-resistant Mycoplasma pneumoniae (MRMP) infections have become increasingly prevalent, espe...
Mycoplasma pneumoniae remains a common cause of community acquired respiratory tract infections in a...
We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan d...
Abstract Background With the emergence of macrolide resistance, concerns about the efficacy of macro...
The molecular characteristics of 480 Mycoplasma pneumoniae polymerase chain reaction-positive specim...
In Korea, Mycoplasma pneumoniae was detected in 255/2,089 respiratory specimens collected during 200...
PurposeMacrolide resistance rate of Mycoplasma pneumoniae has rapidly increased in children. Studies...
To investigate the genetic background for the emergence of macrolide resistance, we characterized th...
Mycoplasma pneumoniae accounts for 10-30% of community-acquired pneumonia (CAP) in children. This st...
To investigate the genetic background for the emergence of macrolide resistance, we characterized th...
The development of macrolide resistance that occurred during 3 days of therapy with azithromycin to ...
Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens a...
SummaryThe development of macrolide resistance that occurred during 3 days of therapy with azithromy...
The resistance rate of 67 Mycoplasma pneumoniae isolates from 356 ambulatory adult patients with res...
Background: The proportion of Mycoplasma pneumoniae isolates carrying point mutations in the 23S reg...
Macrolide-resistant Mycoplasma pneumoniae (MRMP) infections have become increasingly prevalent, espe...
Mycoplasma pneumoniae remains a common cause of community acquired respiratory tract infections in a...
We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan d...
Abstract Background With the emergence of macrolide resistance, concerns about the efficacy of macro...
The molecular characteristics of 480 Mycoplasma pneumoniae polymerase chain reaction-positive specim...